Recent director dealings and insider transactions at Becton, Dickinson and Company (BDX),
from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
Date
Insider
Type
Shares
2026-08-26
Feld Michael
SELL
165
2026-08-20
Feld Michael
SELL
1,049
2026-08-13
Polen Thomas E Jr
SELL
43,278
2026-08-13
Polen Thomas E Jr
SELL
4,152
2026-08-13
Polen Thomas E Jr
SELL
39,126
2026-08-13
Polen Thomas E Jr
BUY
43,278
2026-08-11
Goette Roland
SELL
2,438
2026-08-06
Huffines Robert Luther
BUY
189
2026-08-06
Byington Carrie L
BUY
94
2026-07-27
Feld Michael
SELL
75
Valuation
P/E RatioN/A
Market CapN/A
Beta0.258
Dividend/yrNone
52W High$193.07
52W Low$127.59
52-Week Range
$127.59Now$193.07
87% through annual range
From 52W High−4.3%
From 52W Low+44.8%
📖 Plain English Summary
Becton, Dickinson and Company is at 87% of its 52-week range. Beta 0.258 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for BDX🟢 Bullish⬜ Neutral🔴 Bearish
🤖
DipBuster AI Analysis — BDX
Heuristic · balance sheet, insider filings, price data, academic research
Becton, Dickinson and Company — DipBuster Score 16/100
Graham value assessment, NCAV analysis, price zones...
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supp…